Childbirth, Puerperium and Abortion Care Protocol during the COVID-19 Pandemic

Trapani, Alberto; Vanhoni, Laura Rassi; Silveira, Sheila Koettker; Marcolin, Alessandra Cristina

doi:10.1055/s-0040-1713587

Cited by 18 publications

(36 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition to concerns about breastfeeding and physical distancing outlined above, there has also been debate on SSC. Some earlier recommendations stated that SSC between mother and the newborn should be suspended to prevent COVID‐19 infection 17 . However, later recommendations, including those of WHO, have advocated for SSC.…”

Section: Resultsmentioning

confidence: 99%

“…It was also recommended that the amount of time that the mother and infant remained hospitalized be limited to minimize infection risk. Hospital discharge should ideally occur 24 h after vaginal delivery and 48–96 h after cesarean section 17,19,70 . It was also recommended to limit the number of visitors both in the hospital and in the post‐partum period at home.…”

Section: Resultsmentioning

confidence: 99%

“…Stable newborns should be bathed as soon as possible after birth to remove potential viral particles present in secretions on the skin, particularly if the mother has suspected or confirmed COVID‐19 22,68 . Breastfeeding mothers should wash their hands and wear a three‐ply surgical mask before touching their babies 9–11,17,20,21,53,81 . If a breast pump is used, the mother's breasts, breast pump, and bottle should be cleaned before and after feeding 9,11,13,21,54,81 …”

Section: Resultsmentioning

confidence: 99%

“…For mothers and newborns who roomed in together, it was generally recommended that a two‐meter distance and a physical barrier remain between them when the newborn was not being held 16,53 . Timely discharge from the hospital, social distancing from those outside immediate family, and telehealth were also recommended to reduce COVID exposure in the post‐partum period 17,19,70 …”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

COVID‐19 guidelines for pregnant women and new mothers: A systematic evidence review

DiLorenzo

O’Connor

Ezekwesili

et al. 2021

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Background Nearly a year after COVID‐19 was initially detected, guidance for pregnant and new mothers remains varied. Objective The goal of this systematic review is to summarize recommendations for three areas of maternal and fetal care—breastfeeding, post‐partum social distancing, and decontamination. Search strategy We searched PubMed, Embase and Web of Science spanning from inception to November 9, 2020. Selection criteria Articles were included if they focused on COVID‐positive mothers, commented on at least one of the three areas of interest, and were published in English. Data collection and analysis Our combined database search yielded 385 articles. After removing duplicates and articles that did not cover the correct populations or subject matter, a total of 74 articles remained in our analysis. Main results Most articles recommended direct breastfeeding with enhanced precaution measures. Recommendations regarding post‐partum social distancing varied, although articles published more recently often recommended keeping the mother and newborn in the same room when possible. Decontamination recommendations emphasized mask wearing, good hand hygiene, and proper cleaning of surfaces. Conclusion In general, there was a focus on shared decision making when approaching topics such as breastfeeding and post‐partum social distancing. Guidelines for decontamination were fairly uniform.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

COVID‐19 guidelines for pregnant women and new mothers: A systematic evidence review

DiLorenzo

O’Connor

Ezekwesili

et al. 2021

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

“…So, as a precaution, pregnancy and the puerperium are now considered high-risk situations for severe illness from COVID-19. 37,38 In June 2020, a systematic review 39 of 755 pregnant women presenting with COVID-19 provided only poor-quality evidence, and the authors could not rule out potential worsening of the clinical conditions of pregnant women infected with SARS-CoV-2, or whether the infection is associated with comorbidities or not. Actually, the absence of studies with reliable methodology still greatly limits data interpretation.…”

Section: Covid-19 During Pregnancymentioning

confidence: 99%

COVID-19: Uncertainties from Conception to Birth

Carvalho

Adami

Gonçalves‐Ferri

et al. 2021

Rev Bras Ginecol Obstet

Self Cite

View full text Add to dashboard Cite

Scientific information on the impact of the new coronavirus (SARS-CoV-2) on the health of pregnant women, fetuses and newborns is considered of limited confidence, lacking good-quality evidence, and drawing biased conclusions. As a matter of fact, the initial impressions that the evolution of COVID-19 was no different between pregnant and non-pregnant women, and that SARS-CoV-2 was not vertically transmitted, are confronted by the documentation of worsening of the disease during pregnancy, poor obstetric outcomes, and the possibility of vertical transmission. The present article aims to compile the data available on the association of COVID-19 and reproductive events, from conception to birth.

show abstract

Pregnancy and COVID-19: high or low risk of vertical transmission

et al. 2022

View full text Add to dashboard Cite

Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome 2 (SARS-CoV-2). Throughout the pandemic, evidence on the effects of COVID-19 during pregnancy has been inadequate due to the limited number of studies published. Therefore, the objective of this systematic review was to evaluate current literature regarding the effects of COVID-19 during pregnancy and establish pregnancy outcomes and vertical and perinatal transmission during pregnancy. Multiple databases were searched, including Embase, Medline, Web of Science, Scopus, and Cochrane Central Register of Control Clinical Trials, using the following keywords: [Pregnancy] AND [COVID-19 OR SARS-CoV-2 OR nCoV-19] OR [Perinatal transmission, Vertical transmission (VT), Pregnancy complications], [Pregnancy] AND [Hyperinflammation OR Cytokine storm]. We excluded in vitro and experimental studies, but also ex-vivo and animal study methods. To exclude the risk of bias during data collection and interpretation, all included studies were peer-reviewed publications. This review is estimated to tabulate the study intervention characteristics and compare them against the planned groups for each synthesis. Our findings showed that pregnant women are commonly susceptible to respiratory viral infections and severe pneumonia due to physiological immune suppression and pregnancy-induced changes. VT of SARS-CoV-2 infection during pregnancy is associated with a great deal of controversy and conflict. However, there is still no robust clinical evidence of VT. Furthermore, the clinical presentation and management of COVID-19 during pregnancy are nearly identical to those of non-pregnant women. Finally, chloroquine and remdesivir are the only two drugs evaluated as adequate for the management of COVID-19 during pregnancy.

show abstract

Childbirth, Puerperium and Abortion Care Protocol during the COVID-19 Pandemic

Cited by 18 publications

References 9 publications

COVID‐19 guidelines for pregnant women and new mothers: A systematic evidence review

COVID‐19 guidelines for pregnant women and new mothers: A systematic evidence review

COVID-19: Uncertainties from Conception to Birth

Pregnancy and COVID-19: high or low risk of vertical transmission

Contact Info

Product

Resources

About